PDCD1 and neoplasm: Furthermore, in humanized mouse models, inactivation of KLRB1 in tumor-infiltrating T cells led to enhanced anti-tumor killing, as evidenced by slower tumor progression, significantly increased survival time and increased infiltration of PD1-TIM3- T cells compared to unaltered T cells.